Heart Failure Clinics

Papers
(The median citation count of Heart Failure Clinics is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Unusual Forms of Pulmonary Hypertension26
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure23
Tafamidis in the Treatment of ATTR-related Cardiomyopathy22
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy21
When all Else Fails, Try This20
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias20
Understanding Myocardial Metabolism in the Context of Cardio-Oncology18
Forthcoming Issues17
Changing Landscape of Heart Failure Imaging15
Therapy-Related Clonal Hematopoiesis14
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging14
Preload Reduction Therapies in Heart Failure13
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications13
Genetics of High-Altitude Pulmonary Edema13
Contributors12
Arrhythmias in Adult Congenital Heart Disease Heart Failure12
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now12
Contributors12
Mitral Regurgitation12
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction11
Copyright10
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure10
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure10
Contributors10
Coronary Angiography in the Evaluation of Systolic Heart Failure9
What Is New in Risk Assessment in Nuclear Cardiology?9
Emerging Roles for Artificial Intelligence in Heart Failure Imaging9
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure9
Heart Failure Clinics9
Contributors8
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis8
Hypertrophic Cardiomyopathy8
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy7
Myocardial Dysfunction in Patients with Cancer7
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease7
Specific Therapy in Transthyretin Amyloid Cardiomyopathy7
Guide to Temporary Mechanical Support in Cardiogenic Shock7
Arrythmia-Mediated Valvular Heart Disease7
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging6
Noncoding RNAs in Pulmonary Arterial Hypertension6
Epigenetics of Heart Failure6
Shifting the Epigenetic and Multi-Omic Frontier to Get the Heart in Top Gear6
SGLT2 Inhibitors in Heart Failure6
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population6
Preface6
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging6
Cardiac Contractility Modulation6
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis6
Cardiac Amyloidosis6
Contents5
Copyright5
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study5
Contents5
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes5
Contributors5
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure4
Aortic Valvular Stenosis and Heart Failure4
Evolving Strategies in Cardiac Amyloidosis4
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors4
Adults with Congenital Heart Disease and Transplant4
Contents4
Contents4
Contents4
Copyright4
Contents4
SGLT2 Inhibitors in Type 2 Diabetes Mellitus4
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification4
Clinical Practice Guidelines in Cardio-Oncology3
The Role of Medical Therapy in Hypertrophic Cardiomyopathy3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease3
Pathophysiology of Cardiac Amyloidosis3
Remote Monitoring Devices and Heart Failure3
SGLT2 Inhibitors and Peripheral Vascular Events3
Novel Non-pharmacological Approaches to Heart Failure3
Contributors3
Exercise Testing in Pulmonary Hypertension and Heart Failure3
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy3
Risk Factors for Progression in Hypertrophic Cardiomyopathy3
Forthcoming Issues3
Clinical Use of Biomarkers in Cardiac Amyloidosis3
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-192
Novel Approaches to Sleep Apnea in Heart Failure2
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk2
Adult Congenital Heart Disease2
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?2
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure2
Epigenetic Regulation in Dilated Cardiomyopathy2
Coronary Microvascular Dysfunction2
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy2
Contents2
Contents2
Pulmonary Vascular Disease Across the Continuum: From Mechanisms to Precision Care2
Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome2
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease2
Copyright2
Genetics of Thoracic and Thoracoabdominal Aortic Dissections and Aneurysms2
Forthcoming Issues2
Advances in the Therapy of Light Chain Cardiac Amyloidosis2
Latest Updates in Heart Failure Imaging2
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All2
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification2
Copyright2
Changing Landscape of Heart Failure Imaging2
Contributors2
Forthcoming Issues2
Long-term Complications of Venous Thromboembolism2
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification2
Forthcoming Issues2
Copyright1
Surgical Revascularization Decisions in Ischemia and Heart Failure1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction1
Valvular Heart Failure due to Tricuspid Regurgitation1
Obesity in Heart Failure with Reduced Ejection Fraction1
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease1
Radionuclide Imaging of Infective Endocarditis1
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension1
Mechanical Circulatory Support in COVID-191
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction1
Portopulmonary Hypertension1
Contents1
Copyright1
Novel PET Applications and Radiotracers for Imaging Cardiovascular Pathophysiology1
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?1
Nuclear Cardiology1
Venous Thromboembolism in Women and Gender-Diverse Populations1
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination1
Radionuclide Assessment of Sarcoidosis1
Cardiopulmonary Exercise Testing in Research1
Approach to Mitral Regurgitation in Advanced Heart Failure1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure1
Forthcoming Issues1
Pediatric and Familial Genetic Arrhythmia Syndromes1
Contents1
Challenges in Pulmonary Hypertension1
Contributors1
Patient Selection, Referral Framework and Emerging Therapies in Severe Ischemic Heart Failure1
Contributors1
How to Start an Invasive Cardiopulmonary Exercise Testing Program0
Cardiovascular Effects of COVID-190
Cardiac Amyloidosis0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy0
Advances in Single-Photon Emission Computed Tomography0
Training and Career Development in Cardio-Oncology Translational and Implementation Science0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease0
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology0
Copyright0
Navigating Complexity: Contemporary Patient Selection and Advanced Therapies in Heart Failure0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease0
Secondary Mitral Regurgitation and Heart Failure0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure0
Approach to Ventricular Arrhythmias in Heart Failure0
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management0
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity0
Copyright0
Contributors0
Contents0
Copyright0
Primary Mitral Regurgitation and Heart Failure0
Heart Failure with Reduced Ejection Fraction0
Coronary Artery Disease and Heart Failure0
Advances in the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction0
PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care0
Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker0
Epigenomics and Epigenetics in Heart Failure with Preserved Ejection Fraction0
Navigating the Evolving Landscape of Hypertrophic Cardiomyopathy0
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit0
Contents0
Contents0
Cardioprotection of High-Risk Individuals0
Epigenetic Therapeutics in Human Heart Failure0
Challenges in Pulmonary Hypertension0
Forthcoming Issues0
The War Against Heart Failure Hospitalizations0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice0
Amyloidosis and Amyloidogenesis0
Contributors0
Evaluation of Coronary Artery Disease and Ischemia by Cardiac Magnetic Resonance Imaging0
Viability and Congestive Heart Failure0
T-cell Immunotherapy and Cardiovascular Disease0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus0
Pregnancy and Pulmonary Hypertension0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis0
Sex-Based Differences in Advanced Heart Failure0
Covid-190
Arrhythmic Stratification of Cardiac Amyloidosis0
Stress-First Myocardial Perfusion Imaging0
Tricuspid Regurgitation and Right Heart Failure0
Oxygen Therapy in Pulmonary Vascular Disease0
Optimizing Patient Selection, Referral Timing, and Advanced Therapies in Cardiogenic Shock0
Contents0
Copyright0
Contents0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy0
Forthcoming Issues0
Contents0
Arrhythmogenic Cardiomyopathy0
Copyright0
Obesity Management for Patients with Coronary Artery Disease and Heart Failure0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension0
Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism0
Contributors0
Forthcoming Issues0
Forthcoming Issues0
Unique Challenges of Adult Congenital Heart Disease in CardioOncology0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease0
Valvular Heart Disease and Heart Failure0
Nuclear Cardiology in 20230
Multimodality Imaging in Aortic Stenosis0
Contributors0
Contents0
Contents0
Multimodality Imaging in Hypertrophic Cardiomyopathy0
Interatrial Shunt Devices0
Standard Therapy in Cardiac Amyloidosis0
Strategy for Exercise Restriction in Hypertrophic Cardiomyopathy0
Assessment of Right Ventricle Function and Tricuspid Regurgitation in Heart Failure: Current Advances in Diagnosis and Imaging0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management0
SGLT-2 Inhibitors0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events0
Renoprotective Effects of SGLT2 Inhibitors0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects0
Copyright0
Forthcoming Issues0
Hypertrophic Cardiomyopathy in the Absence of “Hypertrophy”0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography0
Forthcoming Issues0
Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan0
Copyright0
Genotype-Phenotype Correlations in ATTR Amyloidosis0
The Diagnostic and Prognostic Role of Focused Cardiac Ultrasound Performed by Non-cardiologist Specialists in Acute Symptomatic Pulmonary Embolism0
Targeted Therapies for Microvascular Disease0
Long-term Complications of Pulmonary Embolism0
SGLT2 Inhibitors Are Lifesavers in Heart Failure0
Forthcoming Issues0
Contributors0
Contributors0
Contributors0
Heart Failure Preserved Ejection Fraction in Women0
Cardiac Amyloidosis0
The Evolving Landscape of Hypertrophic Cardiomyopathy0
Extracardiac Prothrombotic Effects of COVID-190
Exercise Testing in Elite Athletes0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism0
The Economic Burden of Heart Failure with Reduced Ejection Fraction0
0.087028980255127